Cushing H (1994) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932. Obes Res 2(5):486–508
Article CAS PubMed Google Scholar
Aranda G, Enseñat J, Mora M, Puig-Domingo M, Martínez de Osaba MJ, Casals G et al (2015) Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up. Pituitary 18(1):142–149
Article CAS PubMed Google Scholar
Pendharkar AV, Sussman ES, Ho AL, Hayden Gephart MG, Katznelson L (2015) Cushing’s disease: predicting long-term remission after surgical treatment. Neurosurg Focus 38(2):E13
Etxabe J, Vazquez JA (1994) Morbidity and mortality in Cushing’s disease: an epidemiological approach. Clin Endocrinol (Oxf) 40(4):479–484
Article CAS PubMed Google Scholar
Hameed N, Yedinak CG, Brzana J, Gultekin SH, Coppa ND, Dogan A et al (2013) Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary 16(4):452–458
Article CAS PubMed Google Scholar
Acebes JJ, Martino J, Masuet C, Montanya E, Soler J (2007) Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease. Acta Neurochir (Wien). ;149(5):471-7; discussion 7–9
Fernandez-Rodriguez E, Stewart PM, Cooper MS (2009) The pituitary-adrenal axis and body composition. Pituitary 12(2):105–115
Article CAS PubMed Google Scholar
van Haalen FM, Broersen LH, Jorgensen JO, Pereira AM, Dekkers OM (2015) Management of endocrine disease: mortality remains increased in Cushing’s disease despite biochemical remission: a systematic review and meta-analysis. Eur J Endocrinol 172(4):R143–R149
Locatelli M, Vance ML, Laws ER (2005) Clinical review: the strategy of immediate reoperation for transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 90(9):5478–5482
Article CAS PubMed Google Scholar
Blevins LS Jr., Christy JH, Khajavi M, Tindall GT (1998) Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83(1):63–67
Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C et al (2006) Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 91(1):7–13
Article CAS PubMed Google Scholar
Guo S, Wang Z, Kang X, Xin W, Li X (2021) A Meta-analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas: comparisons of efficacy and safety. Front Neurol. ;12
Gao Y, Zhong C, Wang Y, Xu S, Guo Y, Dai C et al (2014) Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: a meta-analysis. World J Surg Oncol 12:94
Article PubMed PubMed Central Google Scholar
Yu SY, Du Q, Yao SY, Zhang KN, Wang J, Zhu Z, Jiang XB (2018) Outcomes of endoscopic and microscopic transsphenoidal surgery on non-functioning pituitary adenomas: a systematic review and meta-analysis. J Cell Mol Med 22(3):2023–2027
Article PubMed PubMed Central Google Scholar
Broersen LHA, van Haalen FM, Biermasz NR, Lobatto DJ, Verstegen MJT, van Furth WR et al (2019) Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing’s disease: surgical outcome, mortality, and complications. Orphanet J Rare Dis 14(1):64
Article PubMed PubMed Central Google Scholar
Jho HD, Carrau RL (1997) Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 87(1):44–51
Article CAS PubMed Google Scholar
Berker M, Işikay I, Berker D, Bayraktar M, Gürlek A (2014) Early promising results for the endoscopic surgical treatment of Cushing’s disease. Neurosurg Rev 37:105-114
Netea-Maier RT, van Lindert EJ, den Heijer M, van der Eerden A, Pieters GF, Sweep CG et al (2006) Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing’s disease. Eur J Endocrinol 154(5):675–684
Article CAS PubMed Google Scholar
Dehdashti AR, Gentili F (2007) Current state of the art in the diagnosis and surgical treatment of cushing disease: early experience with a purely endoscopic endonasal technique. Neurosurg Focus 23(3):E9
Starke RM, Reames DL, Chen CJ, Laws ER, Jane JA (2013) Jr. Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission. Neurosurgery 72(2):240–247 discussion 7
Sarkar S, Rajaratnam S, Chacko G, Mani S, Hesargatta AS, Chacko AG (2016) Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing’s disease. Acta Neurochir (Wien) 158(1):77–86 discussion
Cebula H, Baussart B, Villa C, Assié G, Boulin A, Foubert L et al (2017) Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing’s disease in 230 patients with positive and negative MRI. Acta Neurochir (Wien) 159(7):1227–1236
Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW et al (2013) Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing’s disease, even in case of macroadenomas or invasive adenomas. Eur J Endocrinol 169(3):329–337
Article CAS PubMed Google Scholar
Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, Schwartz TH (2017) Endoscopic endonasal Versus Microscopic Transsphenoidal surgery for recurrent and/or residual pituitary adenomas. World Neurosurg 101:186–195
Article PubMed PubMed Central Google Scholar
Cavallo LM, Solari D, Tasiou A, Esposito F, de Angelis M, D’Enza AI, Cappabianca P (2013) Endoscopic endonasal transsphenoidal removal of recurrent and regrowing pituitary adenomas: experience on a 59-patient series. World Neurosurg 80(3–4):342–350
Perlman JE, Johnston PC, Hui F et al (2021) Pitfalls in performing and interpreting Inferior Petrosal Sinus Sampling: personal experience and literature review. J Clin Endocrinol Metab 106(5):e1953–e1967. https://doi.org/10.1210/clinem/dgab012
Article PubMed PubMed Central Google Scholar
Yogi-Morren D, Habra MA, Faiman C et al (2015) Pituitary MRI findings in patients with pituitary and ectopic ACTH-dependent cushing syndrome: does a 6-mm pituitary tumor size cut-off value exclude ectopic ACTH syndrome? Endocr Pract 21(10):1098–1103
Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S et al (2017) Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas. J Neurosurg 127(2):397–408
Cooke RS, Jones RA (1994) Experience with the direct transnasal transsphenoidal approach to the pituitary fossa. Br J Neurosurg 8(2):193–196
Article CAS PubMed Google Scholar
Chee GH, Mathias DB, James RA, Kendall-Taylor P (2001) Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome? Clin Endocrinol (Oxf) 54(5):617–626
Article CAS PubMed Google Scholar
Atkinson AB, Kennedy A, Wiggam MI, McCance DR, Sheridan B (2005) Long-term remission rates after pituitary surgery for Cushing’s disease: the need for long-term surveillance. Clin Endocrinol (Oxf) 63(5):549–559
Yap LB, Turner HE, Adams CB, Wass JA (2002) Undetectable postoperative cortisol does not always predict long-term remission in Cushing’s disease: a single centre audit. Clin Endocrinol (Oxf) 56(1):25–31
Article CAS PubMed Google Scholar
Liu X, Dai C, Bao X, Deng K, Yao Y, Sun B et al (2021) Treatment and outcomes of recurrent/persistent Cushing’s disease: a single-center experience. Ann Palliat Med 10(3):2494–2504
Valderrábano P, Aller J, García-Valdecasas L, García-Uría J, Martín L, Palacios N, Estrada J (2014) Results of repeated transsphenoidal surgery in Cushing’s disease. Long-term follow-up. Endocrinol Nutr 61(4):176–183
Wang B, Zheng S, Ren J, Zhong Z, Jiang H, Sun Q et al (2022) Reoperation for Recurrent and Persistent Cushing’s Disease without Visible MRI Findings. J Clin Med 11(22): 6848
Burke WT, Penn DL, Repetti CS, Iuliano S, Laws ERJ (2019) Outcomes after repeat transsphenoidal surgery for recurrent Cushing Disease: updated. Neurosurgery 85(6):E1030–E6
Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M (1996) Treatment of Cushing’s disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. J Endocrinol Invest 19(9):572–580
Article CAS PubMed Google Scholar
Dickerman RD, Oldfield EH (2002) Basis of persistent and recurrent cushing disease: an analysis of findings at repeated pituitary surgery. J Neurosurg 97(6):1343–1349
Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER (2008) Jr. Late recurrences of Cushing’s disease after initial successful transsphenoidal surgery. J Clin Endocrinol Metab 93(2):358–362
Article CAS PubMed Google Scholar
Castinetti F, Brue T, Ragnarsson O (2019) Radiotherapy as a tool for the treatment of Cushing’s disease. Eur J Endocrinol 180(5):D9–d18
留言 (0)